Healthcare Investment in 2006-2016: Error AnalysisJanuary 13, 2017, 09:30 – 11:30, Building 5, 5th Floor, Executive Conference Room
Presentation on the launch of a study of the return on investment in the health care sector of the Russian Federation and generation of proposals for development and investment areas in the Russian health care system.
Issues for Discussion
- The definition of investment in the health system of the Russian Federation: what investments yield tangible results and what are the health care areas that will be able to make the best use of investments?
- How to change the approach to investment in health care: a different perception of investment by health care system participants and legislative changes for better performance and a healthier nation?
- Private investment for the benefit of the State: how to use private capital for the development of the public health care system. Does a healthier nation mean a better return on the investment?
Partner, Life Sciences Leader in Russia and the CIS, EY
First Deputy Minister of Healthcare of the Russian Federation
Director, Social Development Department, Ministry of Economic Development of the Russian Federation
Minister of Healthcare of the Republic of Tatarstan
President, Novartis Group Russia
Vice-Rector for Innovation Development, St. Petersburg State Chemical Pharmaceutical Academy
General Director, Pharmstandart
Company Group Chairman, Janssen Pharmaceutical Companies, Johnson & Johnson
Head, Department for Control over Social Sphere and Commerce, Federal Anti-Monopoly Service
Medical Director, A.S. Khlustin Kaluga City Hospital No. 4
Vice-President, Russia and Eurasia, CEO, AstraZeneca Russia
Vice-President, Head, Eastern Europe, Middle East, Africa, Russia and the CIS, MSD
Senior Vice-President, General Manager, Teva Russia & CIS
Executive Director, Emerging Markets Public Policy MSD